Correlation Between China Pharma and Esperion Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China Pharma and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Pharma and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Pharma Holdings and Esperion Therapeutics, you can compare the effects of market volatilities on China Pharma and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Pharma with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Pharma and Esperion Therapeutics.

Diversification Opportunities for China Pharma and Esperion Therapeutics

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between China and Esperion is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding China Pharma Holdings and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and China Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Pharma Holdings are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of China Pharma i.e., China Pharma and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between China Pharma and Esperion Therapeutics

Given the investment horizon of 90 days China Pharma Holdings is expected to under-perform the Esperion Therapeutics. In addition to that, China Pharma is 1.09 times more volatile than Esperion Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest  633.00  in Esperion Therapeutics on August 28, 2024 and sell it today you would lose (376.00) from holding Esperion Therapeutics or give up 59.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

China Pharma Holdings  vs.  Esperion Therapeutics

 Performance 
       Timeline  
China Pharma Holdings 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in China Pharma Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady technical indicators, China Pharma demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Esperion Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

China Pharma and Esperion Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China Pharma and Esperion Therapeutics

The main advantage of trading using opposite China Pharma and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Pharma position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.
The idea behind China Pharma Holdings and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators